Article Details
Retrieved on: 2022-01-13 19:53:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On January 13, 2022 , Landos Biopharma, Inc. (the "Company") announced that its estimated cash, cash equivalents and short-term investments ...
Article found on: www.marketscreener.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here